Molina Healthcare Inc. (MOH) stock plummeted over 8.52% in the pre-market trading session on Thursday following the healthcare insurer's mixed fourth-quarter results and disappointing earnings guidance for 2025.
While Molina's Q4 revenue of $10.499 billion exceeded analysts' estimates, the company's adjusted earnings per share (EPS) of $5.05 missed the consensus forecast of $5.72. Higher-than-expected medical costs, particularly in the Medicaid business, were cited as the primary reason for the earnings shortfall. Molina's medical care ratio (MCR) rose to 90.2% in Q4, up from 89.1% a year ago, reflecting the impact of acuity shifts and increased utilization related to Medicaid redeterminations.
Furthermore, Molina's adjusted EPS guidance of at least $24.50 for 2025 fell short of analysts' expectations of around $26.07, despite the company forecasting revenue of approximately $44 billion, ahead of estimates. The weaker earnings outlook is attributed to anticipated costs associated with recent contract wins and acquisitions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。